Optimizing Heart Failure Medications in Denver
This study is looking at ways to help people with heart failure (specifically HFrEF, meaning your heart's pumping ability is reduced) get the most out of their medications. Many proven heart failure medicines are not used as much as they could be. This study will compare two approaches: either you'll have extra follow-up visits with a pharmacist who will help adjust your medications and provide simple education, or you'll receive standard care. The goal is to see if these extra pharmacist visits lead to more people starting or increasing their heart failure medications. You might be able to join if you are 18 or older, have HFrEF, and receive care within the DHHA system. You cannot join if you have severe kidney problems or cirrhosis, or if you cannot consent or speak English or Spanish. This study plans to enroll 40 participants.
- Study design
- This is an interventional study that plans to enroll 40 participants. It will compare pharmacist-directed medication adjustments with standard care.
- What's involved
- Participants in the intervention group will have additional follow-up visits with a pharmacy between heart failure provider visits and receive specialized patient education. The primary endpoint is measured up to 3 months after enrollment.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main goal of the study is measured at each visit up to 3 months after you enroll.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
At a glance
Conditions
NCT07435662
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Denver Health and Hospital Authority
Denver, Coloradostudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Proportion of visits with initiation or intensification of heart failure medicationsThis will be assessed at each visit up to 3 months after enrollment.